MRN3.LSE Leverage Shares 3x Long Moderna (MRNA) ETP Securities

- USD
No recent price
Total assets
770K
Expense ratio
0.96%
Dividend yield
-
1-year return
+1,021.90%
Holdings
1
Since
2021

Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.

What does MRN3.LSE invest in?

  • Mostly US stocks (297.2%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (100.0%)
  • Top 3 holdings: 315.2% of the fund

Asset allocation

  • US stocks 297.2%

Top holdings

  • Moderna Inc 315.16%
All holdings, sectors and regions

Leverage Shares 3x Long Moderna (MRNA) ETP Securities performance

Sharpe ratio 0.43
This year
+1,021.90%
1 year
+1,021.90%
3 years
-93.13%
5 years
0.00%

Volatility 356.9% over 1 year and 266.3% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

MRN3.LSE price

Prices on the chart can differ slightly from the closing prices StockSummer shows.